Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
1999-11-17
2002-02-19
Bui, Phuong T. (Department: 1638)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C424S231100, C424S186100, C424S229100, C435S325000, C435S320100, C435S235100, C435S006120, C514S04400A, C536S023100, C536S024100, C536S024320, C536S024330, C530S350000
Reexamination Certificate
active
06348586
ABSTRACT:
Throughout this application, various publications may be referenced by Arabic numerals in brackets. Full citations for these publications may be found at the end of the Detailed Description of the Invention. The disclosures of all publications cited herein are in their entirety hereby incorporated by reference into this application to more fully describe the state of the art to which this invention pertains.
BACKGROUND OF THE INVENTION
Kaposi's sarcoma-associated herpesvirus (KSHV) is a new human herpesvirus (HHV8) believed to cause Kaposi's sarcoma (KS) [1,2].
Kaposi's sarcoma is the most common neoplasm occurring in persons with acquired immunodeficiency syndrome (AIDS). Approximately 15-20% of AIDS patients develop this neoplasm which rarely occurs in immunocompetent individuals. Epidemiologic evidence suggests that AIDS-associated KS (AIDS-KS) has an infectious etiology. Gay and bisexual AIDS patients are approximately twenty times more likely than hemophiliac AIDS patients to develop KS, and KS may be associated with specific sexual practices among gay men with AIDS. KS is uncommon among adult AIDS patients infected through heterosexual or parenteral HIV transmission, or among pediatric AIDS patients infected through vertical HIV transmission. Agents previously suspected of causing KS include cytomegalovirus, hepatitis B virus, human papillomavirus, Epstein-Barr virus (EBV), human herpesvirus 6, human immunodeficiency virus (HIV), and Mycoplasma penetrans. Non-infectious environmental agents, such as nitrite inhalants, also have been proposed to play a role in KS tumorigenesis. Extensive investigations, however, have not demonstrated an etiologic association between any of these agents and AIDS-KS.
SUMMARY OF THE INVENTION
This invention provides an isolated nucleic acid molecule which encodes Kaposi's Sarcoma-Associated Herpesvirus (KSHV) polypeptides. This invention provides an isolated polypeptide molecule of KSHV. This invention provides an antibody specific to the polypeptide. Antisense and triplex oligonucleotide molecules are also provided. This invention provides a vaccine for Kaposi's Sarcoma (KS). This invention provides methods of vaccination, prophylaxis, diagnosis and treatment of a subject with KS and of detecting expression of a DNA virus associated with Kaposi's sarcoma in a cell.
REFERENCES:
patent: 5801042 (1998-09-01), Chang et al.
patent: 5830759 (1998-11-01), Chang et al.
patent: 5861240 (1999-01-01), Ganem
patent: 6093550 (2000-07-01), Chang et al.
patent: 6150093 (2000-11-01), Chang et al.
patent: 6183751 (2001-02-01), Chang et al.
patent: WO9606159 (1996-02-01), None
patent: WO9615779 (1996-05-01), None
patent: WO9712042 (1997-04-01), None
patent: WO9724057 (1997-07-01), None
patent: WO9727208 (1997-07-01), None
patent: WO9803657 (1998-01-01), None
patent: WO9804284 (1998-02-01), None
patent: WO9804576 (1998-02-01), None
patent: WO9811132 (1998-03-01), None
patent: WO9815289 (1998-04-01), None
Muzny et al. Gen Embl Database. Accession No. AC023681, Submitted Feb. 17, 2000.*
Chang et al. Science, vol. 266. Dec. 16, 1994, p 1865-1869.*
Baer et al (1983) DNA sequence and experssion of the B95-8 Epstein-Barr virus genome,Nature310, 207-211.
Mosca et al (1987) Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus,Nature325, 67-70.
Delli Bovi et al (1987) Isolation of a rearranged human transforming gene following transfection of kaposi sarcoma DNA,Proc Natl Acad Sci USA84, 5660-5664.
Gallo (1993) Aspects of the molecular pathogenesis of AIDS,J Cellular Biochem17E, 5.
Gallo (1994) New approaches for interfering with human immunodeficiency virus replication and for Kaposi's sarcoma,J Cellular Biochem18B, 108.
Chang et al (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma,Science265, 1865-1869.
Cesarman et al (1995) Kaposi's sarcoma-associated herpesvirus-like DNA sequences are present in AIDS-related body cavity based lymphomas,The FASEB Journal9, A973, abstract 5650.
Gompels et al (1988) Conservation of glycoprotein H (gH) in herpesviruses: nucleotide sequence of the gH gene from herpesvirus saimiri,J Gen Virol69, 2819-2829.
Gompels et al (1991) Characterization and sequence analyses of antibody-selected antigenic variants of herpes simplex virus show a conformationally complex epitope on glycoprotein H,J Virol65, 2393-2401.
Baer et al (1984) DNA sequence and expression of the B95-8 Epstein-Barr virus genome,Nature310, 207-211.
Mosca et al (1987) Herpes simplex virus type-1 can reactive transcription of latent human immunodeficiency virus,Nature325, 67-70.
Delli Bovi et al (1987) Isolation of a rearranged human transforming gene following transfection of kaposi sarcoma DNA,Proc Natl Acad Sci USA84, 5660-5664.
Gallo (1993) Aspectf of the molecular pathogenesis of AIDS,J Cellular Biochem17E, 5.
Gallo (1994) New approaches for interfering with human immunodeficiency virus replication and for Kaposi's sarcoma,J Cellular Biochem18B, 108.
Chang et al (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma,Science265, 1865-1869.
Cesarman et al (1995) Kaposi's Sarcoma-associated herpesvirus-like DNA sequences are present in AIDS-related body cavity based lymphomas,The FASEB Journal9, A973, abstract 5650.
Gompels et al (1988) Conservation of glycoprotein H (gH) in herpesviruses: nucleotide sequence of the gH gene from herpesvirus saimiri,J Gen Virol69, 2819-2929.
Gompels et al (1991) Characterization and sequence analysis of antibody-selected antigenic variants of herpes simplex virus show a conformationally complex epitope on glycoprotein H,J Virol65, 2393-2401.
Forrester et al (1992) Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequence deleted,J Virol66, 341-348.
Roop et al (1993) A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H,J Virol67, 2285-2297.
Scott et al (1993) Identification and sequence analysis of the homologues of the herpes simplex virus type 1 glycoprotein H in Marek's disease virus and the herpesvirus of turkeys,J Gen Virol74, 1185-1190.
Liu et al (1993) Human herpesvirus-6 glycoprotein H and L homologs are components of the gp100 complex and the gH external domain is the target for neutralizing monoclonal antibodies,Virology197, 12-22.
Tewari et al (1994) Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model,J Gen Virol75, 1735-1741.
McGowan et al (1994) Expression and characterisation of equine herpesvirus 1 glycoprotein H using a recombinant baculovirus,Arch Virol137, 389-395.
Pulford et al (1994) Expression of the Epstein-Barr virus envelope fusion glycoprotein gp85 gene by a recombinant baculovirus,J Gen Virol75, 3241-3248.
Farrell et al (1994) Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deleted,J Virol68, 927-932.
Baranowski et al (1995) Synthesis and processing of bovine herpesvirus-1 glycoprotein H,Virology206, 651-654.
Ambroziak and Blackbourn (1995) Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma,Science268, 582-583.
Bassett et al (1995) Cancer in the African population of Harare, Zimbabwe, 1990-1992,Int J Canc63, 29-36.
Benelli et al (1996) Isolation of spindle-shaped cell populations from primary cultures of Kaposi's sarcoma of different stage,Cancer Lett100, 125-132.
Boshoff et al (1995) Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells,Nat Med1, 1274-1278.
Brady et al (1995) Altered cytokine expression in T lymphocytes from human immunodeficiency virus tat-transgenic mice,J Virol69, 7622-7629.
Braun et al (1995) Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis,Mol Cell Biol15, 4623-4630.
Broder and Karp (1995) Progress against cancer,J Cancer Res121, 633-6
Bohenzky Roy A.
Chang Yuan
Edelman Isidore S.
Moore Patrick S.
Russo James J.
Bui Phuong T.
Cooper & Durham LLP
The Trustees of Columbia University in the City of New York
White John P.
LandOfFree
Unique associated Kaposi's sarcoma virus sequences and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Unique associated Kaposi's sarcoma virus sequences and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Unique associated Kaposi's sarcoma virus sequences and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2936916